The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2013 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2013 AAPM Annual Meeting « Back

    133

    Comfrey Root Extract Plus Methylnicotinate: A Topical Treatment Option for Patients with Acute Upper or Low Back Pain

    Christiane Staiger, christiane.staiger@merckgroup.com1, (1) EMD Consumer Health, Darmstadt, Germany

    Many earlier and recent clinical trials have confirmed the efficacy of comfrey root extract (Symphytum officinale L.) for the topical treatment of painful muscle and joint complaints (1). The topical pharmacotherapeutic approach has generally included hyperaemising topical drugs such as nicotinates with the intention to soften and relax the contracted muscle area. Therefore, the extract has also been used in combination with methylnicotinate. This randomized, multicenter, double-blind, three-arm, placebo-controlled trial compared a topical combination of 35% comfrey root extract plus 1.2% methyl nicotinate versus a single preparation of methyl nicotinate or placebo cream for relief of acute upper or low back pain. 379 patients were randomly assigned to three groups (combination, n=163; methyl nicotinate, n=164; placebo, n=52). They applied a 12 cm layer of cream 3 times daily for 5 days. The trial included four visits and was performed at the German Sport University in Cologne and 3 additional ambulatory centers. The primary efficacy variable was the AUC (area under the curve) of the VAS on active standardized movement values at visits 1 to 4. Secondary measures included back pain at rest, pressure algometry, consumption of analgesic medication, functional impairment measured with Oswestry Disability Index, and global assessment of response. The AUC of the VAS on active standardized movement was markedly smaller in the combination treatment group than in the methyl nicotinate and in the placebo group (ANOVA: p<0.0001). The combination demonstrated superiority to the two other treatment arms, while methyl nicotinate displayed a considerable effect as well. References: 1) Phytother. Res. (2012) DOI: 10.1002/ptr.4612 2) Phytother. Res. (2012) DOI: 10.1002/ptr.4790 3) Br J Sports Med 2010;44:637–641. doi:10.1136/bjsm.2009.058677.

    Funding: This RCT was sponsored by EMD Consumer Health, Darmstadt, Germany

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In